Stories about Gewinn
- One documentmore
- 2
Deutsche Rück Group maintains profit-oriented growth course
more Euroclear reports strong business income growth in Q1 2025
Brussels (ots/PRNewswire) - Results for the first quarter ending 31 March 2025 Financial highlights Strong underlying[1] business growth offsetting lower interest income - Underlying business income for Q1 2025 reached a record €466 million, representing a 10% increase compared to Q1 2024. This growth was supported by robust business drivers, including fixed income issuance, increased equity quotations, and increased ...
moreQ1 2025: RENK doubles order intake and achieves record order backlog
Q1 2025: RENK doubles order intake and achieves record order backlog - Order intake increases by 163.5% to €549 million in the first quarter (Q1 2024: €208 million) - Total order backlog of €5.5 billion sets new record (Q4 2024: €5.0 billion) - Substantial revenue growth of 14.7% to €273 million (Q1 2024: €238 million) - Above-average growth in ...
2 Documentsmore- 2
Fraport Group Records Slightly Lower Result in First Quarter of 2025
2 Documentsmore NTT DATA Business Solutions AG
2New record achieved: NTT DATA Business Solutions exceeds the previous year’s top figures in terms of both revenue and results
more
Instone Group makes a very solid start to the new year with dynamic development in retail sales; full-year targets for 2025 confirmed
One documentmore- 2
Press release / Aurubis AG: Multimetal manufacturer maintains success in challenging market environment
2 Documentsmore Heidelberger Druckmaschinen AG
HEIDELBERG holds its ground in a difficult market environment in FY 2024/25 - targets achieved, significant increase in incoming orders compared to previous year
moreFinancial Report: Motel One Group makes close to a billion / Record sales and strong growth in 2024
Munich (ots) - - At EUR 980 million, the Motel One Group has generated the highest annual turnover in the company’s history. - A stable occupancy rate, hand in hand with dynamic growth: 71 per cent average occupancy rate – supported by strong performance in the final quarter. - Significant increase in EBITDA: management EBITDA has risen to EUR 265 million, an ...
morePM: DHL Group startet mit Umsatz- und Ergebniswachstum in das Jahr 2025 / PR: DHL Group starts 2025 with revenue and earnings growth
DHL Group startet mit Umsatz- und Ergebniswachstum in das Jahr 2025 - Konzernumsatz hat um 2,8 % auf 20.809 Millionen Euro zugelegt (Q1 2024: 20.251 Millionen Euro) - EBIT um 4,5 % auf 1.370 Millionen Euro (Q1 2024: 1.311 Millionen Euro) gestiegen - ...
4 DocumentsmoreGerresheimer: Bormioli Pharma boosts revenues and earnings
Düsseldorf (ots) - - Revenues +11.6%, Adjusted EBITDA +13.1% - Organic development compared to pro forma figures Q1 2024: revenues -6.5%, adjusted EBITDA -9.3% - Q1 significantly influenced by revenue shift in syringe business - Guidance 2025 confirmed: organic revenue growth of 3-5% and adjusted EBITDA margin of 22% Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and ...
more
DEKRA continues on a path of growth and transformation / Future-oriented business model ensures successful fiscal year 2024
moreDeutsche Telekom’s 30th year: on to new records with a constant will to change
moreInstone Group achieves all full year targets; demand expected to pick up significantly in 2025
One documentmoreFiscal year 2024: GEA increases order intake, revenue and profitability
One documentmore- 3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
One documentmore - 2
Press release: Aurubis achieves robust operating result in Q1 2024/25
2 Documentsmore
Good overall result and revenue growth for the ZEISS Group
more- 2
Press release: Aurubis with robust full-year results in a volatile market environment
2 Documentsmore Press Release: STADA welcomes Ingo Schachel as Head of Investor Relations
One documentmoreHeidelberger Druckmaschinen AG
HEIDELBERG anticipates a very strong second half to financial year 2024/2025
moreInstone Group is on track to meet its full year targets with continued solid business performance; private demand is picking up noticeably
One documentmorePM: DHL Group erzielt im dritten Quartal wieder deutliches Umsatzwachstum trotz anhaltend schwacher Weltkonjunktur / PR: DHL Group again posts significant revenue growth in the third quarter despite persistently muted macro dynamics
DHL Group erzielt im dritten Quartal wieder deutliches Umsatzwachstum trotz anhaltend schwacher Weltkonjunktur - Konzernumsatz im dritten Quartal 2024 mit 20,6 Milliarden Euro um 6,2 Prozent über dem Vergleichszeitraum (Q3 2023: 19,4 Milliarden ...
4 Documentsmore
Press release: STADA continues strong growth journey in the first half of 2024
One documentmoreH1 2024 results: RENK Group AG continues successful business development with record figures – more precisely defined financial guidance at upper end of the forecast range
H1 2024 results: RENK Group AG continues successful business development with record figures – more precisely defined financial guidance at upper end of the forecast range - H1 revenue increase to € 510 million (H1 2023: € 410 million) – ...
2 DocumentsmoreInstone Group continues solid performance as planned; continued moderate recovery in demand
One documentmoreHeidelberger Druckmaschinen AG
HEIDELBERG starts the 2024/2025 financial year with a strong order volume from drupa
morePM: DHL Group trifft Markterwartungen im zweiten Quartal / PR: DHL Group meets market expectations in the second quarter
DHL Group trifft Markterwartungen im zweiten Quartal - Konzernumsatz im zweiten Quartal 2024 mit EUR 20,6 Milliarden Euro leicht über dem Vorjahresniveau (Q2 2023: 20,1 Milliarden Euro) - Operatives Ergebnis (EBIT) mit 1,35 Milliarden Euro wie ...
4 DocumentsmorePress release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
One documentmore